Denied
The Board denied the Veteran's appeal to restore a 100% rating for adenocarcinoma of the prostate with urothelial cell carcinoma of the bladder, finding that the reduction from 100% to 20% was proper.
The deciding factor: The Veteran's residual symptoms were noted to be frequency of urination and pain during urination, which equated to a 20 percent rating for urinary frequency under DC 7528.
- Claimed conditions
- adenocarcinoma of the prostate with urothelial cell carcinoma of the bladder
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 20%
- Decision date
- February 28, 2025
- Citation
- A25018438
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.